Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus intramuscular glucocorticoids in rheumatoid arthritis
ISRCTN32090559Phase 3Active, not recruiting
- Sponsor
- The University of Manchester
- Start
- Jul 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of prednisolone and methylprednisolone in rheumatoid arthritis (RA), sponsored by The University of Manchester. Started Jul 2025; status: active, not recruiting.
02
Drugs
prednisolonemethylprednisolone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ISRCTN32090559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN32090559.